How do we best respond to the pain experienced by some of the most frail and vulnerable people in our communities?
The move to prescription-only codeine in Australia has seen a 50% reduction in the monthly rate of codeine-related poisoning calls and halved codeine sales.
A new Australian prevalence study of hidradenitis suppurativa finds a high number of Australians have the devastating skin condition.
Estrogen and other sex hormones may be responsible for the higher prevalence of migraine in women.
A low dose of antidepressants has been shown to help treat back pain in those for whom narcotics are the remaining option.
Over 90% of Australians support the legalisation of medical use cannabis but only a handful of our 38,000 GPs are able to prescribe medicinal cannabis.
Taiwan Stanch has developed an environmentally friendly, re-usable hot/cold pack made from thermal clay.
Health practitioners are being asked to help raise awareness of chronic wounds, especially with at-risk ageing patients.
Does alcohol contribute to PMS, or does PMS drive women to alcohol? Researchers have found the surprising answer.
A man suffered unusual consequences when participating in a hot chilli pepper eating competition.
Worldwide, overuse of inappropriate tests and treatments such as imaging, opioids and surgery means patients are not receiving the right care, and resources are wasted.
A small US study has found that non-opioid-based medicines were as effective as opioid medicines at improving chronic back, hip or knee pain.
Australia is following other countries in curbing access to codeine medications to prevent, reduce and manage codeine addiction. Resources are available to healthcare practitioners to assist with the change.
One hospital alone had $1 million in codeine abuse-related costs.
Patients with chronic health concerns will benefit from a coordinated approach to their care, with trials starting soon.